Submit Deal

Red House Consulting

Summary

Edit Data

Red House is a corporate and investor communications firm specializing in advising emerging life sciences companies.

Market Context

Deals Overview

Edit Data

Total Deals6

Valued Deals5

Total Value£ 608 M

Avg. Deal Size£ 122 M

06 Feb 2025|United States|Biotechnology

Target: ACELYRIN

Bidder: ALUMIS

9 Service Providers

4 Target | 5 Bidder

12 Dealmakers

7 Target | 5 Bidder

£ 255 M

Value

06 Mar 2024|United States|Biotechnology

Target: ALUMIS

Bidder: CORMORANT ASSET MANAGEMENT

6 Service Providers

3 Target | 3 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 204 M

Value

06 Sep 2023|Spain|Medical Services

Target: TRAMONTANE THERAPEUTICS

Bidder: KRIYA THERAPEUTICS INC

5 Service Providers

2 Target | 3 Bidder

4 Dealmakers

1 Target | 3 Bidder

n/a

Value

10 Aug 2023|United States|Pharmaceuticals

Target: SENTI BIO (CHEMISTRY, MANUFACTURING, AND CONTROLS)

Bidder: GENEFAB LLC

7 Service Providers

4 Bidder | 3 Vendor

18 Dealmakers

5 Bidder | 13 Vendor

£ 29 M

Value

22 May 2023|United States|Biotechnology

Target: QUANTA THERAPEUTICS

Bidder: VIDA VENTURES

11 Service Providers

3 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 40 M

Value

06 Jan 2021|United States|Biotechnology

Target: SENTI BIOSCIENCES

Bidder: 8VC

11 Service Providers

2 Target | 9 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 77 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy